Navidea Biopharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NAVB and buy or sell other stocks, ETFs, and their options commission-free!About NAVB
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate.
CEOMichael S. Rosol, PhD
CEOMichael S. Rosol, PhD
Employees—
Employees—
HeadquartersColumbus, Ohio
HeadquartersColumbus, Ohio
Founded1983
Founded1983
Employees—
Employees—
NAVB Key Statistics
Market cap100.00
Market cap100.00
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume2.81K
Average volume2.81K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.05
52 Week high$0.05
52 Week low—
52 Week low—
Stock Snapshot
The current Navidea Biopharmaceuticals(NAVB) stock price is $1.61, with a market capitalization of 100.
On 2026-03-10, Navidea Biopharmaceuticals(NAVB) stock opened at —, reached a high of —, and a low of —.
The Navidea Biopharmaceuticals(NAVB)'s current trading volume is 0, compared to an average daily volume of 2.81K.